BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12775980)

  • 1. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus.
    Pich A; Aloi F; Margaria E; Tomasini C
    Dermatologica; 1991; 183(4):246-50. PubMed ID: 1809585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Tuccari G; Giuffrè G; Lentini M; Batolo D; Catalano A
    Am J Dermatopathol; 2004 Apr; 26(2):171-2; author reply 172-3. PubMed ID: 15024201
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleolar organizer regions in conjunctival nevi and melanomata.
    Koren R; Rath-Wolfson L; Appel I; Pe'er J; Paz A; Klein T; Klein B; Mishaeli M; Gal R
    Oncol Rep; 1998; 5(5):1079-81. PubMed ID: 9683812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ
    Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma.
    Kossard S; Wilkinson B
    J Cutan Pathol; 1995 Apr; 22(2):132-6. PubMed ID: 7560345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS; Gilham P
    Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity in the malignant cellular blue nevus.
    Pich A; Chiusa L; Margaria E; Aloi F
    Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors.
    Khanna AK; Giri AK; Khanna A; Kumar M
    J Surg Oncol; 2001 Dec; 78(4):273-8. PubMed ID: 11745824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity.
    Li LX; Crotty KA; Scolyer RA; Thompson JF; Kril JJ; Palmer AA; McCarthy SW
    Melanoma Res; 2003 Dec; 13(6):581-6. PubMed ID: 14646621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.